Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling

Abstract Muscle satellite stem cells (MuSCs) are responsible for skeletal muscle growth and regeneration. Despite their differentiation potential, human MuSCs have limited in vitro expansion and in vivo migration capacity, limiting their use in cell therapies for diseases affecting multiple skeletal...

Full description

Saved in:
Bibliographic Details
Main Authors: SungWoo Choi, Giulia Ferrari, Louise A Moyle, Kirsty Mackinlay, Naira Naouar, Salma Jalal, Sara Benedetti, Christine Wells, Francesco Muntoni, Francesco Saverio Tedesco
Format: Article
Language:English
Published: Springer Nature 2022-09-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202114526
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332338241044480
author SungWoo Choi
Giulia Ferrari
Louise A Moyle
Kirsty Mackinlay
Naira Naouar
Salma Jalal
Sara Benedetti
Christine Wells
Francesco Muntoni
Francesco Saverio Tedesco
author_facet SungWoo Choi
Giulia Ferrari
Louise A Moyle
Kirsty Mackinlay
Naira Naouar
Salma Jalal
Sara Benedetti
Christine Wells
Francesco Muntoni
Francesco Saverio Tedesco
author_sort SungWoo Choi
collection DOAJ
description Abstract Muscle satellite stem cells (MuSCs) are responsible for skeletal muscle growth and regeneration. Despite their differentiation potential, human MuSCs have limited in vitro expansion and in vivo migration capacity, limiting their use in cell therapies for diseases affecting multiple skeletal muscles. Several protocols have been developed to derive MuSC‐like progenitors from human induced pluripotent stem (iPS) cells (hiPSCs) to establish a source of myogenic cells with controllable proliferation and differentiation. However, current hiPSC myogenic derivatives also suffer from limitations of cell migration, ultimately delaying their clinical translation. Here we use a multi‐disciplinary approach including bioinformatics and tissue engineering to show that DLL4 and PDGF‐BB improve migration of hiPSC‐derived myogenic progenitors. Transcriptomic analyses demonstrate that this property is conserved across species and multiple hiPSC lines, consistent with results from single cell motility profiling. Treated cells showed enhanced trans‐endothelial migration in transwell assays. Finally, increased motility was detected in a novel humanised assay to study cell migration using 3D artificial muscles, harnessing advanced tissue modelling to move hiPSCs closer to future muscle gene and cell therapies.
format Article
id doaj-art-d97ee7a0ff1642abb21d74e59559ab3d
institution Kabale University
issn 1757-4676
1757-4684
language English
publishDate 2022-09-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-d97ee7a0ff1642abb21d74e59559ab3d2025-08-20T03:46:13ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842022-09-01141011910.15252/emmm.202114526Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modellingSungWoo Choi0Giulia Ferrari1Louise A Moyle2Kirsty Mackinlay3Naira Naouar4Salma Jalal5Sara Benedetti6Christine Wells7Francesco Muntoni8Francesco Saverio Tedesco9The Francis Crick InstituteDepartment of Cell and Developmental Biology, University College LondonDepartment of Cell and Developmental Biology, University College LondonDepartment of Cell and Developmental Biology, University College LondonInstitut de Biologie Paris Seine FR3631, Plateforme de Bioinformatique ARTbio, Sorbonne UniversitéThe Francis Crick InstituteUCL Great Ormond Street Institute of Child Health, University College LondonCentre for Stem Cell Systems, The University of MelbourneNational Institute for Health Research Great Ormond Street Hospital Biomedical Research CentreThe Francis Crick InstituteAbstract Muscle satellite stem cells (MuSCs) are responsible for skeletal muscle growth and regeneration. Despite their differentiation potential, human MuSCs have limited in vitro expansion and in vivo migration capacity, limiting their use in cell therapies for diseases affecting multiple skeletal muscles. Several protocols have been developed to derive MuSC‐like progenitors from human induced pluripotent stem (iPS) cells (hiPSCs) to establish a source of myogenic cells with controllable proliferation and differentiation. However, current hiPSC myogenic derivatives also suffer from limitations of cell migration, ultimately delaying their clinical translation. Here we use a multi‐disciplinary approach including bioinformatics and tissue engineering to show that DLL4 and PDGF‐BB improve migration of hiPSC‐derived myogenic progenitors. Transcriptomic analyses demonstrate that this property is conserved across species and multiple hiPSC lines, consistent with results from single cell motility profiling. Treated cells showed enhanced trans‐endothelial migration in transwell assays. Finally, increased motility was detected in a novel humanised assay to study cell migration using 3D artificial muscles, harnessing advanced tissue modelling to move hiPSCs closer to future muscle gene and cell therapies.https://doi.org/10.15252/emmm.202114526cell migrationcell therapyiPS cellsmuscular dystrophytissue engineering
spellingShingle SungWoo Choi
Giulia Ferrari
Louise A Moyle
Kirsty Mackinlay
Naira Naouar
Salma Jalal
Sara Benedetti
Christine Wells
Francesco Muntoni
Francesco Saverio Tedesco
Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
EMBO Molecular Medicine
cell migration
cell therapy
iPS cells
muscular dystrophy
tissue engineering
title Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
title_full Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
title_fullStr Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
title_full_unstemmed Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
title_short Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling
title_sort assessing and enhancing migration of human myogenic progenitors using directed ips cell differentiation and advanced tissue modelling
topic cell migration
cell therapy
iPS cells
muscular dystrophy
tissue engineering
url https://doi.org/10.15252/emmm.202114526
work_keys_str_mv AT sungwoochoi assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT giuliaferrari assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT louiseamoyle assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT kirstymackinlay assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT nairanaouar assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT salmajalal assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT sarabenedetti assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT christinewells assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT francescomuntoni assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling
AT francescosaveriotedesco assessingandenhancingmigrationofhumanmyogenicprogenitorsusingdirectedipscelldifferentiationandadvancedtissuemodelling